Aytu Biopharma Inc (AYTU)

$2.00 +0.01 (0.50%)
Market Cap 21.36M
Revenue (ttm) 66.38M
Net Income (ttm) -13.56M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 7.96
Profit Margin -20.43%
Debt to Equity Ratio 0.62
Volume 28,500
Avg Vol 26,876
Day's Range N/A - N/A
Shares Out 10.73M
Stochastic %K 11%
Beta 0.26
Analysts Strong Sell
Price Target $9.50

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 720 437 6580
Website: aytubio.com
Address:
Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States
Skipper_Jack
Skipper_Jack Sep. 11 at 8:31 PM
$AYTU
0 · Reply
Framingtheworld
Framingtheworld Sep. 9 at 4:52 PM
$XRP.X Alex jones talking about xrp scares me. Last time i bought anything conspiracy related was $AYTU healight bullshit in 2020
0 · Reply
brucino
brucino Sep. 6 at 10:59 PM
$AYTU
1 · Reply
Skipper_Jack
Skipper_Jack Sep. 5 at 11:48 PM
$AYTU Here you go aytu board. You probably should have watched this years and definitely after those two board members quit as a protest. The board of directors has a fiduciary duty to act in the best interests of the company and its shareholders, using care, loyalty, and good faith. Here is a video because some of you must be stupid. https://youtu.be/di_Afm-qCMg?si=sM-q6u6ItA-nt2b_
0 · Reply
KimLam
KimLam Sep. 3 at 10:46 AM
$AYTU sold my last shares of this trash clmpany. 90% loss. Lmao. Stupid nonsense ceo. Delisted (again?) soon.
1 · Reply
Skipper_Jack
Skipper_Jack Sep. 1 at 7:44 PM
$AYTU How is there even volume here? Who is buying this crap?
1 · Reply
inv1ncible
inv1ncible Sep. 1 at 12:08 AM
$AYTU pos scam
0 · Reply
Skipper_Jack
Skipper_Jack Aug. 28 at 9:51 PM
$AYTU Hey Josh, FU buddy! Hope you have a crap weekend.
1 · Reply
Alain_Simard
Alain_Simard Aug. 27 at 3:11 AM
$AYTU I got out of this about 3 weeks ago and put everything into $NLST… so far I made back $45K of my $AYTU losses
3 · Reply
Skipper_Jack
Skipper_Jack Aug. 26 at 4:36 PM
$AYTU Anyone here get paid out on one if the numerous lawsuits against aytu over covid time-frame scandals? I am curious to hear how that went.
0 · Reply
Latest News on AYTU
Aytu BioPharma Transcript: Planet MicroCap Las Vegas 2026

Jun 17, 2026, 1:30 PM EDT - 2 months ago

Aytu BioPharma Transcript: Planet MicroCap Las Vegas 2026

Aytu BioPharma Slides: Corporate presentation

Jun 11, 2026, 7:00 AM EDT - 3 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

Jun 1, 2026, 4:15 PM EDT - 3 months ago

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

AYTU

Aytu BioPharma Transcript: Lytham Partners Spring 2026 Investor Conference

May 28, 2026, 9:15 AM EDT - 3 months ago

Aytu BioPharma Transcript: Lytham Partners Spring 2026 Investor Conference

Aytu BioPharma Slides: Corporate presentation

May 28, 2026, 7:00 AM EDT - 3 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

May 18, 2026, 4:05 PM EDT - 3 months ago

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

AYTU

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

2026-05-13T21:11:01.000Z - 4 months ago

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

AYTU

Aytu BioPharma Earnings Call Transcript: Q3 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

Aytu BioPharma Earnings Call Transcript: Q3 2026

Aytu BioPharma Earnings release: Q3 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

Aytu BioPharma Earnings release: Q3 2026

Aytu BioPharma Quarterly report: Q3 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

Aytu BioPharma Quarterly report: Q3 2026

Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

May 13, 2026, 4:05 PM EDT - 4 months ago

Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

AYTU

Aytu BioPharma Slides: Corporate presentation

May 12, 2026, 7:00 AM EDT - 4 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

May 6, 2026, 4:05 PM EDT - 4 months ago

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

AYTU

Aytu BioPharma Slides: Corporate presentation

Apr 3, 2026, 7:00 AM EDT - 5 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma Slides: Corporate presentation

Mar 17, 2026, 7:00 AM EDT - 6 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

2026-02-03T21:50:30.000Z - 7 months ago

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

AYTU

Aytu BioPharma Earnings Call Transcript: Q2 2026

Feb 3, 2026, 4:30 PM EST - 7 months ago

Aytu BioPharma Earnings Call Transcript: Q2 2026

Aytu BioPharma Quarterly report: Q2 2026

Feb 3, 2026, 4:30 PM EST - 7 months ago

Aytu BioPharma Quarterly report: Q2 2026

Aytu BioPharma Earnings release: Q2 2026

Feb 3, 2026, 4:30 PM EST - 7 months ago

Aytu BioPharma Earnings release: Q2 2026

Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results

Feb 3, 2026, 4:05 PM EST - 7 months ago

Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results

AYTU

Aytu BioPharma Slides: Corporate presentation

Feb 3, 2026, 4:00 PM EST - 7 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

Jan 27, 2026, 4:05 PM EST - 7 months ago

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

AYTU

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

Jan 20, 2026, 4:05 PM EST - 7 months ago

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

AYTU

Aytu BioPharma Transcript: Investor Day 2026

Jan 20, 2026, 11:00 AM EST - 7 months ago

Aytu BioPharma Transcript: Investor Day 2026

Aytu BioPharma Slides: FY 2026

Jan 20, 2026, 11:00 AM EST - 7 months ago

Aytu BioPharma Slides: FY 2026

Aytu BioPharma announces nationwide commercial launch of EXXUA

2026-01-20T14:20:18.000Z - 7 months ago

Aytu BioPharma announces nationwide commercial launch of EXXUA

AYTU

Aytu BioPharma Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Jan 15, 2026, 5:00 PM EST - 8 months ago

Aytu BioPharma Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

Jan 13, 2026, 4:15 PM EST - 8 months ago

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

AYTU

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

Jan 12, 2026, 8:00 AM EST - 8 months ago

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

AYTU

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

Dec 18, 2025, 9:00 AM EST - 9 months ago

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

AYTU

Aytu BioPharma announces commercial availability of EXXUA tablets

2025-12-15T14:20:55.000Z - 9 months ago

Aytu BioPharma announces commercial availability of EXXUA tablets

AYTU

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

Dec 15, 2025, 9:00 AM EST - 9 months ago

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

AYTU

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

Nov 24, 2025, 4:05 PM EST - 9 months ago

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

AYTU

Aytu BioPharma Slides: Corporate presentation

Nov 18, 2025, 7:00 AM EST - 10 months ago

Aytu BioPharma Slides: Corporate presentation

Aytu BioPharma Earnings Call Transcript: Q1 2026

Nov 13, 2025, 4:30 PM EST - 10 months ago

Aytu BioPharma Earnings Call Transcript: Q1 2026

Aytu BioPharma Quarterly report: Q1 2026

Nov 13, 2025, 4:30 PM EST - 10 months ago

Aytu BioPharma Quarterly report: Q1 2026

Aytu BioPharma Earnings release: Q1 2026

Nov 13, 2025, 4:30 PM EST - 10 months ago

Aytu BioPharma Earnings release: Q1 2026

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

Nov 13, 2025, 4:05 PM EST - 10 months ago

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

AYTU

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

Nov 5, 2025, 4:05 PM EST - 10 months ago

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

AYTU

Aytu BioPharma announces patent term extension for EXXUA

2025-10-28T13:20:53.000Z - 10 months ago

Aytu BioPharma announces patent term extension for EXXUA

AYTU

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

Oct 28, 2025, 9:00 AM EDT - 10 months ago

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

AYTU

Aytu BioPharma Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 10 months ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma Proxy statement: Proxy Filing

Oct 24, 2025, 8:00 AM EDT - 10 months ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma Transcript: Planet MicroCap Showcase: TORONTO 2025

Oct 22, 2025, 2:30 PM EDT - 10 months ago

Aytu BioPharma Transcript: Planet MicroCap Showcase: TORONTO 2025

Aytu BioPharma to Present at Upcoming October 2025 Conferences

Oct 10, 2025, 9:00 AM EDT - 11 months ago

Aytu BioPharma to Present at Upcoming October 2025 Conferences

AYTU

Aytu BioPharma management to meet with Lake Street

2025-10-01T14:40:36.000Z - 11 months ago

Aytu BioPharma management to meet with Lake Street

AYTU

Aytu BioPharma Transcript: Lytham Partners Fall 2025 Investor Conference

Sep 30, 2025, 2:45 PM EDT - 11 months ago

Aytu BioPharma Transcript: Lytham Partners Fall 2025 Investor Conference

Aytu BioPharma Transcript: MicroCap Rodeo Fall Conference

Sep 25, 2025, 2:00 PM EDT - 11 months ago

Aytu BioPharma Transcript: MicroCap Rodeo Fall Conference

Aytu BioPharma price target lowered to $7 from $9 at Maxim

2025-09-25T12:05:29.000Z - 11 months ago

Aytu BioPharma price target lowered to $7 from $9 at Maxim

AYTU

Aytu BioPharma to Present at Upcoming September 2025 Conferences

Sep 24, 2025, 4:15 PM EDT - 11 months ago

Aytu BioPharma to Present at Upcoming September 2025 Conferences

AYTU

Aytu BioPharma price target lowered to $7 from $9 at Maxim

2025-09-24T16:16:41.000Z - 11 months ago

Aytu BioPharma price target lowered to $7 from $9 at Maxim

AYTU

Aytu BioPharma Earnings Call Transcript: Q4 2025

Sep 23, 2025, 4:30 PM EDT - 11 months ago

Aytu BioPharma Earnings Call Transcript: Q4 2025

Aytu BioPharma Annual report: Q4 2025

Sep 23, 2025, 4:30 PM EDT - 11 months ago

Aytu BioPharma Annual report: Q4 2025

Aytu BioPharma Earnings release: Q4 2025

Sep 23, 2025, 4:30 PM EDT - 11 months ago

Aytu BioPharma Earnings release: Q4 2025

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

Sep 23, 2025, 4:05 PM EDT - 11 months ago

Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)

AYTU

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

Sep 16, 2025, 4:05 PM EDT - 12 months ago

Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025

AYTU

Aytu BioPharma management to meet with Maxim

2025-07-08T17:45:24.000Z - 1 year ago

Aytu BioPharma management to meet with Maxim

AYTU

Aytu BioPharma initiated with a Buy at Lake Street

2025-07-01T12:55:58.000Z - 1 year ago

Aytu BioPharma initiated with a Buy at Lake Street

AYTU

Aytu BioPharma initiated with a Buy at Ascendiant

2025-06-30T09:20:10.000Z - 1 year ago

Aytu BioPharma initiated with a Buy at Ascendiant

AYTU

Aytu BioPharma appoints Gerwin Westfield as SVP, scientific affairs

2025-06-25T12:30:52.000Z - 1 year ago

Aytu BioPharma appoints Gerwin Westfield as SVP, scientific affairs

AYTU

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Jun 25, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

AYTU

Aytu BioPharma expands, extends lending agreement with Eclipse

2025-06-23T17:53:35.000Z - 1 year ago

Aytu BioPharma expands, extends lending agreement with Eclipse

AYTU

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Jun 23, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

AYTU

Aytu BioPharma Transcript: Investor Update

Jun 11, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Transcript: Investor Update

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 9, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

AYTU

Aytu BioPharma 9.6M share Secondary priced at $1.50

2025-06-06T12:45:21.000Z - 1 year ago

Aytu BioPharma 9.6M share Secondary priced at $1.50

AYTU

Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals

2025-06-06T12:15:35.000Z - 1 year ago

Aytu BioPharma enters exclusive agreement with Fabre-Kramer Pharmaceuticals

AYTU

Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering

2025-06-06T12:15:25.000Z - 1 year ago

Aytu BioPharma prices 9.6M shares at $1.50 in upsized public offering

AYTU

Aytu BioPharma announces exclusive commercialization agreement for Exxua

2025-06-06T12:15:20.000Z - 1 year ago

Aytu BioPharma announces exclusive commercialization agreement for Exxua

AYTU

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:01 AM EDT - 1 year ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

AYTU

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Jun 6, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

AYTU

Aytu BioPharma Registration statement: Registration Filing

Jun 5, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Registration statement: Registration Filing

Aytu BioPharma files to sell 6.74M shares of common stock

2025-06-02T21:20:08.000Z - 1 year ago

Aytu BioPharma files to sell 6.74M shares of common stock

AYTU

Aytu BioPharma Registration statement: Registration Filing

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Registration statement: Registration Filing

Aytu BioPharma Earnings Call Transcript: Q3 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Earnings Call Transcript: Q3 2025

Aytu BioPharma Quarterly report: Q3 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Quarterly report: Q3 2025

Aytu BioPharma Earnings release: Q3 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Earnings release: Q3 2025

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 14, 2025, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

AYTU

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

May 7, 2025, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

AYTU

Aytu BioPharma Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 23, 2025, 4:30 PM EDT - 1 year ago

Aytu BioPharma Transcript: Planet MicroCap Showcase: VEGAS 2025

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:05 PM EDT - 1 year ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

AYTU

Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation

2025-04-14T22:15:09.000Z - 1 year ago

Aytu BioPharma’s treatment of Marfan syndrome receives FDA orphan designation

AYTU

Aytu BioPharma Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 12, 2025, 4:03 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

AYTU

Aytu BioPharma Earnings Call Transcript: Q2 2025

Feb 12, 2025, 4:00 PM EST - 1 year ago

Aytu BioPharma Earnings Call Transcript: Q2 2025

Aytu BioPharma Quarterly report: Q2 2025

Feb 12, 2025, 4:00 PM EST - 1 year ago

Aytu BioPharma Quarterly report: Q2 2025

Aytu BioPharma Earnings release: Q2 2025

Feb 12, 2025, 4:00 PM EST - 1 year ago

Aytu BioPharma Earnings release: Q2 2025

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Feb 5, 2025, 5:50 PM EST - 1 year ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

AYTU

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

AYTU

Aytu BioPharma Disclosure Notification

Dec 3, 2024, 11:45 PM EST - 1 year ago

Aytu BioPharma Disclosure Notification

AYTU

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 22, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

AYTU

Aytu BioPharma Earnings Call Transcript: Q1 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aytu BioPharma Earnings Call Transcript: Q1 2025

Aytu BioPharma Quarterly report: Q1 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aytu BioPharma Quarterly report: Q1 2025

Aytu BioPharma Earnings release: Q1 2025

Nov 13, 2024, 4:30 PM EST - 1 year ago

Aytu BioPharma Earnings release: Q1 2025

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 13, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

AYTU

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Nov 6, 2024, 5:20 PM EST - 1 year ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

AYTU

Aytu BioPharma Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 16, 2024, 2:00 PM EDT - 1 year ago

Aytu BioPharma Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

AYTU

Aytu BioPharma Registration statement: Registration Filing

Oct 11, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Registration statement: Registration Filing

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Oct 1, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

AYTU

Aytu BioPharma Earnings Call Transcript: Q4 2024

Sep 26, 2024, 4:30 PM EDT - 1 year ago

Aytu BioPharma Earnings Call Transcript: Q4 2024

Aytu BioPharma Earnings release: Q4 2024

Sep 26, 2024, 4:30 PM EDT - 1 year ago

Aytu BioPharma Earnings release: Q4 2024

Aytu BioPharma Annual report: Q4 2024

Sep 26, 2024, 4:30 PM EDT - 1 year ago

Aytu BioPharma Annual report: Q4 2024

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 26, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

AYTU

Aytu BioPharma Registration statement: Registration Filing

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Registration statement: Registration Filing

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Sep 19, 2024, 5:30 PM EDT - 1 year ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

AYTU

Aytu BioPharma Transcript: Sidoti Micro-Cap Virtual Conference

Aug 15, 2024, 12:15 PM EDT - 2 years ago

Aytu BioPharma Transcript: Sidoti Micro-Cap Virtual Conference

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 8, 2024, 5:20 PM EDT - 2 years ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

AYTU

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aug 6, 2024, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

AYTU

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Jun 18, 2024, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

AYTU

Aytu BioPharma Earnings Call Transcript: Q3 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Aytu BioPharma Earnings Call Transcript: Q3 2024

Aytu BioPharma Quarterly report: Q3 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Aytu BioPharma Quarterly report: Q3 2024

Aytu BioPharma Earnings release: Q3 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

Aytu BioPharma Earnings release: Q3 2024

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 15, 2024, 4:05 PM EDT - 2 years ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

AYTU

Aytu BioPharma Proxy statement: Proxy Filing

May 10, 2024, 8:00 AM EDT - 2 years ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma Proxy statement: Proxy Filing

May 10, 2024, 8:00 AM EDT - 2 years ago

Aytu BioPharma Proxy statement: Proxy Filing

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

May 8, 2024, 4:15 PM EDT - 2 years ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

AYTU

Aytu BioPharma Transcript: Emerging Growth Conference

Apr 4, 2024, 4:40 PM EDT - 2 years ago

Aytu BioPharma Transcript: Emerging Growth Conference

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 2 years ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

AYTU

Aytu BioPharma Earnings Call Transcript: Q2 2024

Feb 14, 2024, 4:30 PM EST - 2 years ago

Aytu BioPharma Earnings Call Transcript: Q2 2024

Aytu BioPharma Quarterly report: Q2 2024

Feb 14, 2024, 4:30 PM EST - 2 years ago

Aytu BioPharma Quarterly report: Q2 2024

Aytu BioPharma Earnings release: Q2 2024

Feb 14, 2024, 4:30 PM EST - 2 years ago

Aytu BioPharma Earnings release: Q2 2024

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 14, 2024, 4:05 PM EST - 2 years ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

AYTU

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Feb 7, 2024, 4:15 PM EST - 2 years ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

AYTU

Aytu BioPharma Transcript: Lytham Partners 2024 Select Conference

Feb 1, 2024, 11:45 AM EST - 2 years ago

Aytu BioPharma Transcript: Lytham Partners 2024 Select Conference

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 23, 2024, 9:00 AM EST - 2 years ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

AYTU

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 30, 2023, 8:00 AM EST - 2 years ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

AYTU

Aytu BioPharma Earnings Call Transcript: Q1 2024

Nov 14, 2023, 4:30 PM EST - 2 years ago

Aytu BioPharma Earnings Call Transcript: Q1 2024

Aytu BioPharma Quarterly report: Q1 2024

Nov 14, 2023, 4:30 PM EST - 2 years ago

Aytu BioPharma Quarterly report: Q1 2024

Aytu BioPharma Earnings release: Q1 2024

Nov 14, 2023, 4:30 PM EST - 2 years ago

Aytu BioPharma Earnings release: Q1 2024

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

AYTU

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 8, 2023, 8:30 AM EST - 2 years ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

AYTU

Skipper_Jack
Skipper_Jack Sep. 11 at 8:31 PM
$AYTU
0 · Reply
Framingtheworld
Framingtheworld Sep. 9 at 4:52 PM
$XRP.X Alex jones talking about xrp scares me. Last time i bought anything conspiracy related was $AYTU healight bullshit in 2020
0 · Reply
brucino
brucino Sep. 6 at 10:59 PM
$AYTU
1 · Reply
Skipper_Jack
Skipper_Jack Sep. 5 at 11:48 PM
$AYTU Here you go aytu board. You probably should have watched this years and definitely after those two board members quit as a protest. The board of directors has a fiduciary duty to act in the best interests of the company and its shareholders, using care, loyalty, and good faith. Here is a video because some of you must be stupid. https://youtu.be/di_Afm-qCMg?si=sM-q6u6ItA-nt2b_
0 · Reply
KimLam
KimLam Sep. 3 at 10:46 AM
$AYTU sold my last shares of this trash clmpany. 90% loss. Lmao. Stupid nonsense ceo. Delisted (again?) soon.
1 · Reply
Skipper_Jack
Skipper_Jack Sep. 1 at 7:44 PM
$AYTU How is there even volume here? Who is buying this crap?
1 · Reply
inv1ncible
inv1ncible Sep. 1 at 12:08 AM
$AYTU pos scam
0 · Reply
Skipper_Jack
Skipper_Jack Aug. 28 at 9:51 PM
$AYTU Hey Josh, FU buddy! Hope you have a crap weekend.
1 · Reply
Alain_Simard
Alain_Simard Aug. 27 at 3:11 AM
$AYTU I got out of this about 3 weeks ago and put everything into $NLST… so far I made back $45K of my $AYTU losses
3 · Reply
Skipper_Jack
Skipper_Jack Aug. 26 at 4:36 PM
$AYTU Anyone here get paid out on one if the numerous lawsuits against aytu over covid time-frame scandals? I am curious to hear how that went.
0 · Reply
Skipper_Jack
Skipper_Jack Aug. 26 at 4:27 PM
$AYTU This is a dilution company that dabbles in novel (albeit) worthless medical products. Don't buy this trash. JD is a crook whore.
0 · Reply
PremiumHEDGE
PremiumHEDGE Aug. 25 at 9:20 PM
$AYTU Imagine if message board had AI in 2020 … Audio ON 🔊
0 · Reply
LeopoldRothschild
LeopoldRothschild Aug. 21 at 7:53 PM
$AYTU 6 years and still no prison for no one. Fuck you all.
1 · Reply
Skipper_Jack
Skipper_Jack Aug. 21 at 6:11 PM
$AYTU I wonder what sh*thead JD is doing this weekend besides counting is money and having relations with his secretary at a cheap motel. What a scumbag.
0 · Reply
KuntaKinteh
KuntaKinteh Aug. 11 at 9:10 PM
$AYTU Was reading that article on news just mow, So, The Company Will make Profit in 2028? 😶‍🌫️When it will break even? So, all investors money were gone starting in 2021, when Dishbrow took iver 300 Mil USD amd vanished it and this Smack is literally deceiving his investors still in 2026? What to beeak even? Lies and Fraud at Tops by. A CRIMiNAL!!! Where’s your Buddy, JOSH? HAL MINTZ am talking about!!!! What a LOW LIFE DISBROW IS!!!
0 · Reply
KuntaKinteh
KuntaKinteh Aug. 11 at 1:55 PM
$AYTU U are Feeding a Hair Paint run by A CROOK thag Have Nothing Yo DonWoth Pharma or this Pompos Name, Autu Biopharma. If U see that Old Creepy Commercial woth Bold Peps, Covering Their Bold ies, Well, THIS OS THE AYTU BIOPHARMA!!! S C A M!!’ U cam call The Feds amd Expose This Trash LYING SCUM, JOSH DIDHBROW!!!! Where Are Inveators Money???? What Have You Done woth the Hundreds Of Million SINCE 2021??? What A LOW LIFE YOU ARE, DISHBROW!!!! Stip Giving Money to thjs Crook!!!
0 · Reply
Alain_Simard
Alain_Simard Aug. 10 at 3:29 PM
$AYTU I knew this was going to happen… sold everything Thursday and this happens on Monday
1 · Reply
Skipper_Jack
Skipper_Jack Aug. 6 at 1:10 PM
$AYTU There definitely is 40K people following this stupid, worthless company. Those ST accounts are all from the Pandemic time and are washed out.
0 · Reply
Skipper_Jack
Skipper_Jack Jul. 30 at 12:30 AM
$AYTU I wonder if they'll let JD ring the market opening bell again with his disgusting and money- hungry pig of a wife by his side? What a dumpy woman.
0 · Reply
KuntaKinteh
KuntaKinteh Jul. 28 at 2:25 PM
$AYTU Indeed but he Aint a Doctor! He also make the President Look Bad in Pandemic woth The Healight amd anothe Lie, Mount Sinai Research. Dishbrow didnt even import a Covid Rapid Test!!! I hope He gets in JAIL!!!
0 · Reply
Skipper_Jack
Skipper_Jack Jul. 28 at 12:08 PM
$AYTU Market cap $23M... that is less than a quarter of what was invested into your dilution/RS scam during covid under false pretenses. My hands off to you JD and your window licking brother.
0 · Reply
KuntaKinteh
KuntaKinteh Jul. 28 at 11:39 AM
$AYTU This TRASH CEO, JOsH DISHBROW have toasted INVESTORS MONEY SINCE PANDEMIC. A Hair Paint company Transformed The TiTLE In PHARMA amd Stolen HUNDREDS OF MIL $ FROM HIS INVESTORS SINCE PANDEMIC, WITH FAKE PROMISES LIKE COVID TESTS, HEALIGHT, ORPHAN DRUG MERGING WITH CERECOR amd TAKING INVESTORS MONEY OUTA COMPANY!!! THIS FUTURE CON MAN, SUCCEDED TO PUMP AYTU PAINT with THE PRESIDENT Of ThE US in that time!!!! How this CRiMINAL CONTINUE TO TRADE THIS SCAM ON US MARKETS? HOW?
0 · Reply